UPDATE: Synergy Pharma (SGYP) Reports In-Line Q3 EPS, Revenues Miss; Lowers FY18 Revenues Below Consensus & Below Min. Revenue Covenant on Loan Agreement
Go back to UPDATE: Synergy Pharma (SGYP) Reports In-Line Q3 EPS, Revenues Miss; Lowers FY18 Revenues Below Consensus & Below Min. Revenue Covenant on Loan Agreement| SYNERGY PHARMA (NASDAQ: SGYP) | Delayed: 0.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.03 | 52 Week High | $6.58 | |||
| Open | $59.45 | 52 Week Low | $2.50 | |||
| Day High | $0.03 | P/E | N/A | |||
| Day Low | $0.03 | EPS | $-0.70 | |||
| Volume | 62,153 | |||||

